Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
143M
-
Shares change
-
+3.23M
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$32.2M
-
Put/Call ratio
-
0.86
-
Number of buys
-
87
-
Number of sells
-
-82
-
Price
-
$8.32
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2024
210 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q3 2024.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 143M shares
of 316M outstanding shares and own 45.13% of the company stock.
Largest 10 shareholders include UBS Group AG (21.8M shares), VANGUARD GROUP INC (14.6M shares), BlackRock, Inc. (12.4M shares), TPG GP A, LLC (12.3M shares), Rubric Capital Management LP (10.7M shares), CITADEL ADVISORS LLC (8.89M shares), DIMENSIONAL FUND ADVISORS LP (4.71M shares), NEUBERGER BERMAN GROUP LLC (3.79M shares), GEODE CAPITAL MANAGEMENT, LLC (3.79M shares), and STATE STREET CORP (3.51M shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.